What Artia Global Partners LP reported holding on Form 13F for the quarter ended Sep 30, 2026.
CIK 1937964 · Filed Nov 16, 2026
Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR
| 185.4K |
| ±0% |
| $38.1M |
| 7.7% |
ABVXAbivax S.A. | 364.3K | −29.5% | $36.1M | 7.3% |
BTSGBrightSpring Health Services, Inc. | 609.9K | +17.9% | $34.6M | 7% |
TRVITrevi Therapeutics, Inc. | 2.2M | ±0% | $31.7M | 6.4% |
ARGXArgenx SE | 29.7K | ±0% | $28.5M | 5.8% |
TVTXTravere Therapeutics, Inc. | 398.5K | +17.5% | $23.5M | 4.7% |
ALKSAlkermes plc. | 449K | ±0% | $18.2M | 3.7% |
GHGuardant Health, Inc. | 96.7K | +153.8% | $17.2M | 3.5% |
AZNAstraZeneca PLC | 98.4K | ±0% | $15.9M | 3.2% |
DGXQuest Diagnostics Inc | 65.1K | ±0% | $15.2M | 3.1% |
DNTHDianthus Therapeutics, Inc. | 165.7K | +1.7% | $14.6M | 2.9% |
RVTYRevvity, Inc. | 80.9K | New | $12.4M | 2.5% |
NAMSNewAmsterdam Pharma Co N.V. | 503.9K | ±0% | $12.3M | 2.5% |
MRKMerck & Co., Inc. | 80.5K | +72.4% | $11.7M | 2.4% |
JNJJohnson & Johnson | 27.1K | +19.9% | $7.2M | 1.4% |
BRKRBruker Corp | 103.8K | New | $6.7M | 1.4% |
BIIBBiogen Inc. | 29.2K | +58.6% | $6.6M | 1.3% |
EWTXEdgewise Therapeutics, Inc. | 161.2K | +63.1% | $6.5M | 1.3% |
VKTXViking Therapeutics, Inc. | 180.7K | ±0% | $5.9M | 1.2% |
RAPPRapport Therapeutics, Inc. | 166.5K | +20.2% | $5.6M | 1.1% |
TMOThermo Fisher Scientific Inc. | 7.6K | New | $5.1M | 1% |
ABSIAbsci Corp | 464.4K | ±0% | $5M | 1% |
ROIVRoivant Sciences Ltd. | 129.8K | ±0% | $4.7M | 1% |
CYTKCytokinetics Inc | 70.7K | ±0% | $4.7M | 0.9% |
SRRKScholar Rock Holding Corp | 96.3K | ±0% | $4.7M | 0.9% |
BLTEBelite Bio, Inc | 25K | ±0% | $4.2M | 0.9% |
TXG10x Genomics, Inc. | 46.3K | New | $4.2M | 0.8% |
ASNDAscendis Pharma A/S | 17.7K | ±0% | $4M | 0.8% |
CELCCelcuity Inc. | 50.5K | −14.8% | $4M | 0.8% |
| 20K | New | $3.9M | 0.8% |
GRALGrail, Inc. | 25.2K | New | $3.5M | 0.7% |
MLYSMineralys Therapeutics, Inc. | 137.8K | ±0% | $3.5M | 0.7% |
ELVNEnliven Therapeutics, Inc. | 72.1K | ±0% | $3.3M | 0.7% |
PTGXProtagonist Therapeutics, Inc | 23K | ±0% | $3.2M | 0.7% |
TWSTTwist Bioscience Corp | 15.3K | New | $3M | 0.6% |
ORKAOruka Therapeutics, Inc. | 33.4K | ±0% | $2.8M | 0.6% |
UTHRUnited Therapeutics Corp | 5K | ±0% | $2.7M | 0.5% |
KNSAKiniksa Pharmaceuticals International, plc | 29.2K | ±0% | $2.2M | 0.4% |
CORTCorcept Therapeutics Inc | 18K | New | $2.1M | 0.4% |
DRUGBright Minds Biosciences Inc. | 38.4K | ±0% | $1.9M | 0.4% |
EYPTEyePoint, Inc. | 464.7K | −39.4% | $1.5M | 0.3% |
RXRXRecursion Pharmaceuticals, Inc. | 334.4K | New | $1.4M | 0.3% |
AAgilent Technologies, Inc. | 5.8K | New | $999.4K | 0.2% |
PROKProkidney Corp. | 553.7K | −69.4% | $919.2K | 0.2% |
PRAXPraxis Precision Medicines, Inc. | 2.5K | ±0% | $728.1K | 0.1% |
PEPGPepGen Inc. | 205.3K | ±0% | $496.9K | 0.1% |
MBXMBX Biosciences, Inc. | 8.3K | New | $486.5K | 0.1% |
SYRESpyre Therapeutics, Inc. | 4K | ±0% | $356.1K | 0.1% |
DNAGinkgo Bioworks Holdings, Inc. | 20.4K | New | $262.3K | 0.1% |
CLYMClimb Bio, Inc. | 21.1K | New | $242K | 0.1% |